Growing up in New York, Unger completed his medical degree at Columbia University and then directed a project to detect diabetes for the US Public Health Services
Their potential for weight loss was discovered as patients began reporting unintended weight loss as a side effect during diabetes treatment trials
Survodutide is still in earlier testing, which means approval may take a little longer
Wagoner J, Negash A, Kane O, Martnez L, Nahmias Y, Bourne N, Kane OJ, Martinez LE, Owen DM, Grove J, Brimacombe C, McKeating JA, Pcheur E-I, Graf TN, Oberlies NH, Lohmann V, Cao F, Tavis JE, Polyak SJ, Polyak S (2010) Multiple effects of silymarin on the hepatitis C virus lifecycle
Tirzepatide showed up to 20% weight loss in obese individuals and significant HbA 1c reduction in type 2 diabetes patients